FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer

被引：0
|
作者：
Cuilan Sun
Weiwei Gao
Jiatao Liu
Hao Cheng
Jiqing Hao
机构：
[1] The First Affiliated Hospital of Anhui Medical University,Department of Oncology
[2] the First Affiliated Hospital of Anhui Medical University,Department of Pharmacy
来源：
Respiratory Research | / 21卷
关键词：
Fibrinogen-like-protein 1; Epidermal growth factor receptor; Non-small cell lung cancer; Gefitinib resistance; Apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Erlotinib/gefitinib/osimertinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2021, 1850 (1) : 131 - 131
  • [32] Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization
    Yeung, Yiu To
    Yin, Shuying
    Lu, Bingbing
    Fan, Suyu
    Yang, Ran
    Bai, Ruihua
    Zhang, Chengjuan
    Bode, Ann M.
    Liu, Kangdong
    Dong, Zigang
    EBIOMEDICINE, 2018, 28 : 51 - 61
  • [33] Effects of BTK inhibitor on gefitinib-resistance non-small cell lung cancer
    Hong, T-M.
    Fang, Y-T.
    Chen, Y-L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Src mediates ERK reactivation in gefitinib resistance in non-small cell lung cancer
    Ochi, Nobuaki
    Takigawa, Nagio
    Harada, Daijiro
    Yasugi, Masayuki
    Ichihara, Eiki
    Hotta, Katsuyuki
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    EXPERIMENTAL CELL RESEARCH, 2014, 322 (01) : 168 - 177
  • [35] Overexpression of Cathepsin L is associated with gefitinib resistance in non-small cell lung cancer
    F. Cui
    W. Wang
    D. Wu
    X. He
    J. Wu
    M. Wang
    Clinical and Translational Oncology, 2016, 18 : 722 - 727
  • [36] ARID1A is downregulated in non-small cell lung cancer and regulates cell proliferation and apoptosis
    Zhang, Yi
    Xu, Xiaoman
    Zhang, Meng
    Bai, Xue
    Li, Hui
    Kan, Liang
    Niu, Huiyan
    He, Ping
    TUMOR BIOLOGY, 2014, 35 (06) : 5701 - 5707
  • [37] β-Catenin overexpression is associated with gefitinib resistance in non-small cell lung cancer cells
    Fang, Xia
    Gu, Pan
    Zhou, Caicun
    Liang, Aibin
    Ren, Shenxiang
    Liu, Fang
    Zeng, Yu
    Wu, Yunjin
    Zhao, Yinmin
    Huang, Binbin
    Zhang, Zongmei
    Yi, Xianghua
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 28 (01) : 41 - 48
  • [38] Gefitinib/osimertinibAcquired resistance in advanced non-small cell lung cancer: case report
    Reactions Weekly, 2021, 1863 (1) : 165 - 165
  • [39] Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
    Araki, Takuya
    Yashima, Hideaki
    Shimizu, Kimihiro
    Aomori, Tohru
    Hashita, Tadahiro
    Kaira, Kyoichi
    Nakamura, Tomonori
    Yamamoto, Koujirou
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [40] Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small cell lung cancer cell lines
    Li, Zi-Xuan
    Qu, Lian-Yue
    Hi-Wen
    Zhong, Hong-Shan
    Xu, Ke
    Qiu, Xue-Shan
    Wang, En-Hua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (10): : 7304 - 7311
12345